Page 20 - Sun Pharma
Sun Pharma, ICGEB tie up to develop dengue vaccine
Sun Pharma will fund and support further development of the vaccine
 "Sun Pharma, ICGEB tie up to develop dengue vaccine")
Sun will recall 31,762 bottles of anti-depressant
This is a class III recall initiated voluntarily by Sun
 "Sun will recall 31,762 bottles of anti-depressant")
Sun Pharma recalls 31,762 bottles of antidepressant drug in US
The tablets have been manufactured by Sun Pharma at its Halol plant
 "Sun Pharma recalls 31,762 bottles of antidepressant drug in US")
Sun Pharma, Ranbaxy medical reps called for talks
The medical reps contend Sun management has been "arbitrarily" transferring them after taking control
 "Sun Pharma, Ranbaxy medical reps called for talks")
New products, campaigns to boost Sun Pharma OTC sales
After tying up with Nykaa, pharma major plans to sell products online
 "New products, campaigns to boost Sun Pharma OTC sales")
Sun Pharma's high cash levels draw criticism
Firm says treasury team has done a commendable job
Should one participate in the Sun Pharma buyback offer?
Here is an opportunity to get a 13% return in less than a month; the trouble is that the buyback ratio isn't exciting
 "Should one participate in the Sun Pharma buyback offer?")
Sun Pharma medical representatives to go on strike
The strike is also against company's decision to have a uniform structure for paid leave for employees
Sun Pharma to start 14 brand transfers from Novartis
Mitsubishi Tanabe Pharma Corporation will market and distribute all the 14 brands
Sun Pharma inks distribution alliance with Mitsubishi Tanabe
Sun Pharma forayed into Japanese prescription market by acquiring 14 brands from Novartis for $293 million
FDA warns former Sun Pharma US drug factory over quality concerns
The company has been pulled up by USFDA for using contaminated raw materials
 "FDA warns former Sun Pharma US drug factory over quality concerns")
Sun Pharma Q1 net zooms over 3-fold at Rs 2,034 cr on strong US sales
Overall consolidated revenue grew 23% to Rs 8,007 cr
 "Sun Pharma Q1 net zooms over 3-fold at Rs 2,034 cr on strong US sales")
Sun Pharma: Guidance overhang despite good Q1 show
Approvals for US launches and clearance of Halol plant key for Sun Pharma's earning upgrades
 "Sun Pharma: Guidance overhang despite good Q1 show")
Sun Pharma Q1 net zooms over 3-fold to Rs 2,034 crore
Company's consolidated total income from operations rose to Rs 8,242.99 crore for the first quarter of the current fiscal
Sun Pharma to launch diabetes tablet in US
Tablets may have an annual sales of around $1.2 billion in the country
Sun Pharma, Almirall enter pact for psoriasis novel biologic
Sun Pharma to receive $50 mn initially, apart from development & regulatory milestone payments, royalties on net sales
 "Sun Pharma, Almirall enter pact for psoriasis novel biologic")
Sun Pharmaceutical gains on pact with Almirall for Psoriasis drug
Under terms of the license agreement, Almirall will pay Sun Pharma an initial upfront payment of US $50 million,
 "Sun Pharmaceutical gains on pact with Almirall for Psoriasis drug")
Sun Pharma in $50 million deal with Spanish firm Almirall
According to Sun Pharma, Almirall will be able to lead European studies, and participate in larger Global clinical studies for psoriasis indication subject to the terms of the Sun Pharma - Merck agreements
 "Sun Pharma in $50 million deal with Spanish firm Almirall")
Sun, Glenmark, Aurobindo get USFDA nod for cholesterol drug Crestor
Crestor tablets had posted annual sales of around $6.78 billion in the 12 months ended May 2016
SPARC and Sun Pharma ink licensing pact for epilepsy drug
Shares of SPARC were trading 5.11% at Rs 367.50 apiece on BSE
